Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011, Article ID 432917, 7 pages
http://dx.doi.org/10.1155/2011/432917
Case Report

TFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature

1Department of Urology, Texas Tech University Health Sciences Center, Medical Office Plaza, Lubbock, TX 79415, USA
2Department of Pediatrics, Texas Tech University Health Sciences Center, Lubbock, TX 79430-8115, USA
3Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, TX 79430-9406, USA

Received 13 June 2011; Accepted 14 July 2011

Academic Editor: Peter Michael Kroisel

Copyright © 2011 T. Nelius et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. H. Chow, L. M. Dong, and S. S. Devesa, “Epidemiology and risk factors for kidney cancer,” Nature Reviews Urology, vol. 7, no. 5, pp. 245–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Renshaw, S. R. Granter, J. A. Fletcher, H. P. Kozakewich, C. L. Corless, and A. R. Perez-Atayde, “Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes,” American Journal of Surgical Pathology, vol. 23, no. 7, pp. 795–802, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. W. G. Kaelin, “Von Hippel-Lindau disease,” Annual Review of Pathology, vol. 2, pp. 145–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Wu, C. I. Amos, Y. Zhu et al., “Telomere dysfunction: a potential cancer predisposition factor,” Journal of the National Cancer Institute, vol. 95, no. 16, pp. 1211–1218, 2003. View at Google Scholar · View at Scopus
  5. R. Bouillon, G. Eelen, L. Verlinden, C. Mathieu, G. Carmeliet, and A. Verstuyf, “Vitamin D and cancer,” Journal of Steroid Biochemistry and Molecular Biology, vol. 102, no. 1–5, pp. 156–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. M. Dong, P. Brennan, S. Karami et al., “An analysis of growth, differentiation and apoptosis genes with risk of renal cancer,” PLoS One, vol. 4, no. 3, Article ID e4895, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. García-Closas, N. Malats, D. Silverman et al., “NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses,” The Lancet, vol. 366, no. 9486, pp. 649–659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Karami, P. Brennan, P. S. Rosenberg et al., “Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk,” PLoS One, vol. 4, no. 9, Article ID e7013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. E. Moore, P. Brennan, S. Karami et al., “Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk,” Cancer Research, vol. 69, no. 20, pp. 8001–8008, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Semenza, A. Ziogas, J. Largent, D. Peel, and H. Anton-Culver, “Gene-environment interactions in renal cell carcinoma,” American Journal of Epidemiology, vol. 153, no. 9, pp. 851–859, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Simic, A. Savic-Radojevic, M. Pljesa-Ercegovac, M. Matic, and J. Mimic-Oka, “Glutathione S-transferases in kidney and urinary bladder tumors,” Nature Reviews Urology, vol. 6, no. 5, pp. 281–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Valdivielso and E. Fernandez, “Vitamin D receptor polymorphisms and diseases,” Clinica Chimica Acta, vol. 371, no. 1-2, pp. 1–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Cheng, S. Zhang, G. T. MacLennan, A. Lopez-Beltran, and R. Montironi, “Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms,” Human Pathology, vol. 40, no. 1, pp. 10–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Sudarshan and W. M. Linehan, “Genetic basis of cancer of the kidney,” Seminars in Oncology, vol. 33, no. 5, pp. 544–551, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Argani, C. R. Antonescu, P. B. Illei et al., “Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents,” American Journal of Pathology, vol. 159, no. 1, pp. 179–192, 2001. View at Google Scholar · View at Scopus
  16. P. Argani and M. Ladanyi, “Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions,” in World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, J. N. Eble, G. Sauter, J. I. Epstein, and I. A. Sesterhenn, Eds., pp. 37–38, IARC Press, Lyon, France, 2004. View at Google Scholar
  17. A. Lopez-Beltran, M. Scarpelli, R. Montironi, and Z. Kirkali, “2004 WHO classification of the renal tumors of the adults,” European Urology, vol. 49, no. 5, pp. 798–805, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Komai, M. Fujiwara, Y. Fujii et al., “Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry,” Clinical Cancer Research, vol. 15, no. 4, pp. 1170–1176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Mathur, S. Das, and H. H. Samuels, “PSF-TFE3 oncoprotein in papillary renal cell carcinoma inactivates TFE3 and p53 through cytoplasmic sequestration,” Oncogene, vol. 22, no. 32, pp. 5031–5044, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Argani, C. R. Antonescu, J. Couturier et al., “PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21),” American Journal of Surgical Pathology, vol. 26, no. 12, pp. 1553–1566, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Meloni, R. M. Dobbs, J. E. Pontes, and A. A. Sandberg, “Translocation (X;1) in papillary renal cell carcinoma: a new cytogenetic subtype,” Cancer Genetics and Cytogenetics, vol. 65, no. 1, pp. 1–6, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Pérot, L. Boccon-Gibod, R. Bouvier et al., “Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study,” Cancer Genetics and Cytogenetics, vol. 143, no. 2, pp. 93–99, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Tonk, K. S. Wilson, C. F. Timmons, N. R. Schneider, and G. E. Tomlinson, “Renal cell carcinoma with translocation (X;1): further evidence for a cytogenetically defined subtype,” Cancer Genetics and Cytogenetics, vol. 81, no. 1, pp. 72–75, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Hua, X. Liu, D. O. Ansari, and H. F. Lodish, “Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene,” Genes and Development, vol. 12, no. 19, pp. 3084–3095, 1998. View at Google Scholar · View at Scopus
  25. E. Steingrímsson, L. Tessarollo, B. Pathak et al., “Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 7, pp. 4477–4482, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Argani, S. Olgac, S. K. Tickoo et al., “Xp11 Translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum,” American Journal of Surgical Pathology, vol. 31, no. 8, pp. 1149–1160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H. B. Armah and A. V. Parwani, “Renal cell carcinoma in a 33-year-old male with an unusual morphology and an aggressive clinical course: possible Xp11.2 translocation,” Pathology, vol. 40, no. 3, pp. 306–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. I. M. Bovio, R. W. Allan, B. R. Oliai, T. Hampton, and D. S. Rush, “XpII.2 translocation renal carcinoma with placental metastasis: a case report,” International Journal of Surgical Pathology, vol. 19, no. 1, pp. 80–83, 2011. View at Publisher · View at Google Scholar
  29. P. Camparo, V. Vasiliu, V. Molinie et al., “Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature,” American Journal of Surgical Pathology, vol. 32, no. 5, pp. 656–670, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Koie, T. Yoneyama, Y. Hashimoto et al., “An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man,” International Journal of Urology, vol. 16, no. 3, pp. 333–335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Rais-Bahrami, J. J. Drabick, A. M. De Marzo et al., “Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy,” Urology, vol. 70, no. 1, pp. 178.e3–178.e6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. G. G. Malouf, P. Camparo, S. Oudard et al., “Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network,” Annals of Oncology, vol. 21, no. 9, pp. 1834–1838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Indolfi, M. Terenziani, F. Casale et al., “Renal cell carcinoma in children: a clinicopathologic study,” Journal of Clinical Oncology, vol. 21, no. 3, pp. 530–535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. Aronson, I. Medary, J. L. Finlay, H. W. Herr, P. R. Exelby, and M. P. La Quaglia, “Renal cell carcinoma in childhood and adolescence: a retrospective survey for prognostic factors in 22 cases,” Journal of Pediatric Surgery, vol. 31, no. 1, pp. 183–186, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. J. I. Geller and J. S. Dome, “Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma,” Cancer, vol. 101, no. 7, pp. 1575–1583, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Al-Saleem, L. L. Wessner, B. W. Scheithauer et al., “Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex,” Cancer, vol. 83, no. 10, pp. 2208–2216, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. J. B. Nelson, R. Oyasu, and D. P. Dalton, “The clinical and pathological manifestations of renal tumors in von Hippel-Lindau disease,” Journal of Urology, vol. 152, no. 6, pp. 2221–2226, 1994. View at Google Scholar · View at Scopus
  38. J. R. Gnarra, K. Tory, Y. Weng et al., “Mutations of the VHL tumour suppressor gene in renal carcinoma,” Nature Genetics, vol. 7, no. 1, pp. 85–90, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Argani, P. Lal, B. Hutchinson, M. Y. Lui, V. E. Reuter, and M. Ladanyi, “Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay,” American Journal of Surgical Pathology, vol. 27, no. 6, pp. 750–761, 2003. View at Publisher · View at Google Scholar · View at Scopus